| 2021-11-05 | 10-Q | 10.7 | Modification No. 30, effective September 30, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development Authority to Emergent Manufacturing Operations Baltimore LLC. |
|---|
| 2021-11-05 | 10-Q | 10.6 | Modification No. 25, effective September 29, 2021, to the CDC BioThrax Procurement Contract. |
|---|
| 2021-11-05 | 10-Q | 10.5 | Modification No. 24, effective February 2, 2021, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and Prevention to Emergent Biodefense Operations Lansing LLC. |
|---|
| 2021-11-05 | 10-Q | 10.4 | Modification No. 11, effective September 30, 2021, to the BARDA AV7909 Contract. |
|---|
| 2021-11-05 | 10-Q | 10.3 | Modification No. 2, effective August 29, 2018, to the BARDA AV7909 Contract. |
|---|
| 2021-11-05 | 10-Q | 10.2 | Modification No. 1, effective March 16 2017, to the BARDA AV7909 Contract. |
|---|
| 2021-11-05 | 10-Q | 10.1 | Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development Gaithersburg Inc. |
|---|
| 2021-09-09 | 8-K/A | 10.1 | The CDC BioThrax Procurement Contract, effective December 8, 2016. |
|---|
| 2021-07-30 | 10-Q | 10.17 | Change Order No. 13 to Work Order #5997-01, effective April 23, 2021, to AZ MSA1 (included under AZ MSA 2). |
|---|
| 2021-07-30 | 10-Q | 10.16 | Change Order No. 10 to Work Order #5997-01, effective March 10, 2021, to AZ MSA1 (included under AZ MSA2). |
|---|
| 2021-07-30 | 10-Q | 10.15 | Change Order No. 6 to Work Order #5997-01, effective October 13, 2020, to AZ MSA1 (included under AZ MSA2). |
|---|
| 2021-07-30 | 10-Q | 10.14 | Change Order No. 5 to Work Order #5997-01, effective September 16, 2020, to AZ MSA1 (included under AZ MSA 2). |
|---|
| 2021-07-30 | 10-Q | 10.13 | Change Order No. 4 to Work Order #5997-01, effective November 17, 2020, to AZ MSA1 (included under AZ MSA2). |
|---|
| 2021-07-30 | 10-Q | 10.12 | Change Order No. 2 to Work Order #5997-01, effective August 04, 2020, to AZ MSA1 (included under AZ MSA2). |
|---|
| 2021-07-30 | 10-Q | 10.11 | Change Order No. 1 to Work Order #5997-01, effective July 31, 2020, to Manufacturing Services Agreement, dated June 10, 2020, between Emergent Manufacturing Operations Baltimore, LLC and AstraZeneca Pharmaceuticals LP (AZ MSA1) (included under Manufacturing Services Agreement, dated July 24, 2020, by and between Emergent Manufacturing Operations Baltimore, LLC and AstraZeneca Pharmaceuticals LP (AZ MSA2). |
|---|
| 2021-07-30 | 10-Q | 10.10 | Modification No. 7, effective May 24, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated May 24, 2020 (Task Order 75A50120F33007), the BARDA ADM Contract. |
|---|
| 2021-07-30 | 10-Q | 10.9 | Modification No. 1, effective April 12, 2021, to Task Order 75A50120F33006. |
|---|
| 2021-07-30 | 10-Q | 10.8 | Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated April 2, 2020, under the BARDA ADM Contract (Task Order 75A50120F33006). |
|---|
| 2021-07-30 | 10-Q | 10.7 | Modification No. 28, effective May 27, 2021, to the BARDA ADM Contract. |
|---|
| 2021-07-30 | 10-Q | 10.6 | Modification No. 27, effective May 6, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development Authority to Emergent Manufacturing Operations Baltimore LLC. |
|---|
| 2021-07-30 | 10-Q | 10.5 | Modification No. 3, effective, April 1, 2021, to the Award/Contract, effective August 30, 2019 (ACAM2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human Services to Emergent Product Development Gaithersburg Inc. |
|---|
| 2021-07-30 | 10-Q | 10.4 | Modification No. 10, effective June 10, 2021 to the BARDA AV7909 Contract. |
|---|
| 2021-07-30 | 10-Q | 10.3 | Modification No. 9, effective April 21, 2021, to the BARDA AV7909 Contract. |
|---|
| 2021-07-30 | 10-Q | 10.2 | Modification No. 8, effective March 22, 2021, to the BARDA AV7909 Contract. |
|---|
| 2021-07-30 | 10-Q | 10.1 | Modification No. 7, effective December 2, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development Gaithersburg Inc. (the BARDA AV7909 Contract). |
|---|
| 2021-04-30 | 10-Q | 10.7 | Amendment No. 4, effective January 21, 2021, to AZ MSA. |
|---|
| 2021-04-30 | 10-Q | 10.6 | Amendment No. 3, effective November 25, 2020, to AZ MSA. |
|---|
| 2021-04-30 | 10-Q | 10.5 | Amendment No. 2, effective October 30, 2020, to Manufacturing Services Agreement, dated July 24, 2020, by and between Emergent Manufacturing Operations Baltimore, LLC and AstraZeneca Pharmaceuticals LP (AZ MSA). |
|---|
| 2021-04-30 | 10-Q | 10.4 | Amendment No. 1, effective February 25, 2021, to Manufacturing Services Agreement, dated July 1, 2020, by and between Emergent Manufacturing Operations Baltimore, LLC and Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. |
|---|
| 2021-04-30 | 10-Q | 10.3 | Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007. |
|---|
| 2021-04-30 | 10-Q | 10.2 | Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007. |
|---|
| 2021-04-30 | 10-Q | 10.1 | Modification No. 4, effective January 29, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated May 24, 2020 (Task Order 75A50120F33007), under the Award/Contract, effective August 30, 2019 (BARDA ADM Conract), from the Assistant Secretary, U.S. Department of Health and Human Services (ASPR/OPM) to Emergent Product Development Gaithersburg Inc. |
|---|
| 2021-02-19 | 10-K | 10.77 | Modification No. 26, effective November 2, 2020 to the BARDA ADM Contract. |
|---|
| 2021-02-19 | 10-K | 10.68 | Modification No. 2, effective November 17, 2020, to Task Order 75A50120F33008. |
|---|
| 2021-02-19 | 10-K | 10.65 | Modification No. 3, effective October 7, 2020, to Task Order 75A50120F33007. |
|---|
| 2021-02-19 | 10-K | 10.64 | Modification No. 2, effective September 18, 2020, to Task Order 75A50120F33007. |
|---|
| 2021-02-19 | 10-K | 10.60 | Modification No. 2, effective, October 28, 2020 to the ACAM 2000 Contract. |
|---|
| 2021-02-19 | 10-K | 10.47 | Modification No. 23, effective September 30, 2020, to the CDC BioThrax Procurement Contract. |
|---|
| 2021-02-19 | 10-K | 10.46 | Modification No. 22 to the CDC BioThrax Procurement Contract. |
|---|
| 2021-02-19 | 10-K | 10.45 | Modification No. 21, effective January 7, 2020, to the CDC BioThrax Procurement Contract. |
|---|
| 2021-02-19 | 10-K | 10.13 | Global Form of Restricted Stock Unit Award Agreement. |
|---|